These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18656818)

  • 21. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
    Armstrong D
    Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Are dilated intercellular spaces an invariable histological sign for gastro-oesophageal reflux disease?].
    Vieth M
    Z Gastroenterol; 2006 Apr; 44(4):341-3. PubMed ID: 16625464
    [No Abstract]   [Full Text] [Related]  

  • 23. Gastroesophageal reflux disease is frequently present in patients with laryngeal and voice disorders.
    Pellicano R; Fagoonee S
    Saudi Med J; 2008 Feb; 29(2):315; author reply 315. PubMed ID: 18246253
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical characteristics of gastroesophageal reflux disease in Japan.
    Yamagishi H; Koike T; Ohara S; Abe Y; Iijima K; Imatani A; Kato K; Shibuya D; Aida S; Shimosegawa T
    Hepatogastroenterology; 2009; 56(93):1032-4. PubMed ID: 19760935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres.
    Danjo A; Yamaguchi K; Fujimoto K; Saitoh T; Inamori M; Ando T; Shimatani T; Adachi K; Kinjo F; Kuribayashi S; Mitsufuji S; Fujiwara Y; Koyama S; Akiyama J; Takagi A; Manabe N; Miwa H; Shimoyama Y; Kusano M
    J Gastroenterol Hepatol; 2009 Apr; 24(4):633-8. PubMed ID: 19220681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AGA Institute medical position statement on the use of endoscopic therapy for gastroesophageal reflux disease.
    Falk GW; Fennerty MB; Rothstein RI
    Gastroenterology; 2006 Oct; 131(4):1313-4. PubMed ID: 17030198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AGA Institute technical review on the use of endoscopic therapy for gastroesophageal reflux disease.
    Falk GW; Fennerty MB; Rothstein RI
    Gastroenterology; 2006 Oct; 131(4):1315-36. PubMed ID: 17030199
    [No Abstract]   [Full Text] [Related]  

  • 28. Non-erosive reflux disease--defining the entity and delineating the management.
    Modlin IM; Hunt RH; Malfertheiner P; Moayyedi P; Quigley EM; Tytgat GN; Tack J; Holtmann G; Moss SF
    Digestion; 2008; 78 Suppl 1():1-5. PubMed ID: 18832833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease.
    Bhardwaj A; Hollenbeak CS; Pooran N; Mathew A
    Am J Gastroenterol; 2009 Jun; 104(6):1533-9. PubMed ID: 19491867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoscopy-negative reflux disease: part of the spectrum of gastro-oesophageal reflux disease [corrected] or a separate disorder? Implications for treatment.
    Galmiche JP
    Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():9-10, 21-4. PubMed ID: 15755268
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage.
    Bredenoord AJ; Hemmink GJ; Smout AJ
    Neurogastroenterol Motil; 2009 Aug; 21(8):807-12. PubMed ID: 19374635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subdividing functional dyspepsia: a paradigm shift?
    Talley NJ
    Gut; 2008 Nov; 57(11):1487-9. PubMed ID: 18941000
    [No Abstract]   [Full Text] [Related]  

  • 34. Computer analysis of upper gastrointestinal endoscope images.
    Wertheim D; El Atar A; Patel A; Makanjuola O; Imam A; Mudan S; Fiennes A
    Minim Invasive Ther Allied Technol; 2005; 14(1):39-44. PubMed ID: 16754152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing gastroesophageal reflux disease: the pathologist's perspective.
    Allende DS; Yerian LM
    Adv Anat Pathol; 2009 May; 16(3):161-5. PubMed ID: 19395879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients with physiological acid exposure and positive symptom association scores: a distinct group within the GORD spectrum.
    de Vries DR; van Herwaarden MA; Smout AJ; Samsom M
    Neurogastroenterol Motil; 2009 Aug; 21(8):820-e53. PubMed ID: 19239623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Proposal for a new endoscopic classification of the gastroesophageal reflux disease].
    Vasil'ev IuV
    Eksp Klin Gastroenterol; 2005; (3):64-8. PubMed ID: 16255556
    [No Abstract]   [Full Text] [Related]  

  • 38. Questionnaires in gastroesophageal reflux disease: what do the answers mean?
    Holloway RH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1311-2. PubMed ID: 19702895
    [No Abstract]   [Full Text] [Related]  

  • 39. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication.
    Broeders JA; Draaisma WA; Bredenoord AJ; de Vries DR; Rijnhart-de Jong HG; Smout AJ; Gooszen HG
    Br J Surg; 2009 Sep; 96(9):1023-30. PubMed ID: 19672931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: endoscopic antireflux procedures - an unfulfilled promise?
    Pace F; Costamagna G; Penagini R; Repici A; Annese V
    Aliment Pharmacol Ther; 2008 Mar; 27(5):375-84. PubMed ID: 18162082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.